Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.49
-7.50%
Yahoo Finance · 10/30/2026
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-30.7%
3 months
-19.5%
6 months
-17.7%
1 year
-66.3%
Year to date
-52.7%
52-week range
$1.49 – $5.05
Latest reported period: Jun 30, 2026
Market cap
$32.8M
P/E
-0.2
P/B
0.1
P/S
1.5
Revenue
$21.5M
Net income
-$166.98M
Diluted EPS
-6.4
Gross margin
-162.40%
Net margin
-776.60%
Return on equity
-32.70%
Total debt
$229.13M
Cash
$8.96M
Free cash flow
-$113.08M
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | — | — | — |
| Jun 30, 2026 | — | — | — | — | — |
| Dec 31, 2025 | — | — | — | — | — |
| Dec 31, 2025 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Support WBURModerna and Merck recently released remarkable new results of the personalized cancer vaccine.Here & Now's Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and...
Original sourceSubscribe to CNBC PROSubscribe to Investing ClubLicensing & ReprintsCNBC CouncilsJoin the CNBC PanelDigital ProductsNews ReleasesClosed CaptioningCorrectionsAbout CNBCInternshipsSite...
Original sourceAdam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The...
Original sourceU.S. stock futures tracked mixed overnight late on Sunday, as last week's sharp selloff in technology stocks weighed on the Nasdaq even as markets brace for crucial earnings updates.As of 10:20 p.m. EDT, Dow futures gained 0.22%, and S&P 500 futures were up 0.11%. Nasdaq-100 futures were down 0.02...
Original sourceMADRID — In a testament to clinicians’ interest in Merck and Moderna’s personalized cancer vaccine data at this year’s European Society for Medical Oncology conference, the ... ...
Original source